drugset / Trial / NCT00589979

Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee

NCT00589979

Phase 2 Completed 169 enrolled Endo USA Inc., a Keenova Therapeutics Company
RandomizedCrossoverTriple-blindTreatment

Summary

Patients with knee pain due to Osteoarthritis (OA) experiencing sub-optimal pain relief from their current analgesic regimen will participate in a pilot clinical trial to evaluate the effectiveness and tolerability of the Lidoderm Patch compared with placebo in treating knee pain from OA.

Timeline

Start
2007-03
Primary completion
2008-06
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 % Topical

Indications